Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2026-02-16
Germany The Tender Involves The Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Relugolix, Atc L02bx04, For The Period From October 1, 2025, To September 30, 2027. This Agreement Allows Health Insurance 2026-02-16
Germany Pharmaceutical Discounts According To § 130a Para. 8 Sgb V As Part Of Openhouse Processes 2026-02-16
Germany Pharmaceutical Discounts According To § 130a Para. 8 Sgb V As Part Of Openhouse Processes 2026-02-16
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Calcium Carbonate+colecalciferol, Atc A12ax01 F.d.z. 01.10.25-30.09.27 (plus Extension Option 1x12 Months) 2026-02-16
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2026-02-16
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Hydrocortisone (exclusive Dafo Tab), Atc H02ab09 F.d.z. 01.10.25-30.09.27 (plus Extension Option 1x12 Months) 2026-02-16
Germany Rifampicin (fta: 450mg, 600mg (n1, N3))_tk, Hek, Hkk 2026-02-16
Germany Ibuprofen (otc: Fixed Oral Drf, Except Pul, Gra) _tk, Hek, Hkk 2026-02-16
Germany Risperidone (parenteral Depot Forms Of Depot: 75mg, 100mg) _tk, Hek, Hkk 2026-02-16
Whats app